Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
Johnson & Johnson(JNJ) stock is priced at $207.90, giving the company a market capitalization of 500.12B. It carries a P/E multiple of 20.04 and pays a dividend yield of 2.5%.
On 2025-12-30, Johnson & Johnson(JNJ) stock moved within a range of $207.38 to $209.47. With shares now at $207.90, the stock is trading +0.3% above its intraday low and -0.7% below the session's peak.
Trading volume for Johnson & Johnson(JNJ) stock has reached 4.35M, versus its average volume of 8.35M.
The stock's 52-week range extends from a low of $140.68 to a high of $215.19.
The stock's 52-week range extends from a low of $140.68 to a high of $215.19.
JNJ News
After Johnson & Johnson (JNJ) recently reported that the Phase 2b DUPLEX-AD proof-of-concept study of JNJ-95475939 for the treatment of moderate to severe atopi...
Key Points Microsoft is a terrific growth stock with an excellent dividend program. Johnson & Johnson and Coca-Cola are both outstanding dividend payers. How...
On Friday, Johnson & Johnson (NYSE:JNJ) shared the planned interim analysis from Phase 2b DUPLEX-AD proof-of-concept study of JNJ-95475939 for moderate to sever...
Analyst ratings
56%
of 27 ratingsMore JNJ News
Johnson & Johnson JNJ, like any other large drugmaker, boasts a robust R&D pipeline of drugs, with its key focus areas being immunology, oncology and neuroscien...
Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel , our YieldBoost fo...
A Baltimore jury has ordered Johnson & Johnson (JNJ) and its subsidiaries to pay more than $1.5B to a woman who said decades of exposure to asbestos in the comp...
Erik Haas, worldwide VP of litigation, Johnson & Johnson said: “We will immediately appeal this egregious and patently unconstitutional verdict that is the dire...
A Baltimore city jury ordered Johnson & Johnson to pay over $1.5 billion in a lawsuit that alleged the company’s talc-based personal products gave a Maryland wo...
Key Points Coca-Cola has increased its dividend for 63 straight years. Johnson & Johnson has matched Coca-Cola's dividend growth streak. Consolidated Edison...
Johnson & Johnson (JNJ) has quietly climbed about 17% over the past 3 months and roughly 44% year to date, putting the spotlight back on what investors are real...
